| Die meistzitierten Artikel | Die meistzitierten Reviews | Die meistzitierten Köpfe |
Bild der meistzitierten Köpfe |
||
Die meistzitierten Artikel |
|||
| Rang | Autoren | Paper | Zitierungen |
| 1. | Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B | Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. JOURNAL OF NEUROSCIENCE 18: (1) 559-572 JAN 1 1998 | 146 |
| 2. | Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, Meier PJ | The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. JOURNAL OF BIOLOGICAL CHEMISTRY 273: (16) 10046-10050 APR 17 1998 | 137 |
| 3. | Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B | Association of a human G-protein beta 3 subunit variant with hypertension. NATURE GENETICS 18: (1) 45-48 JAN 1998 | 117 |
| 4. | Sachse C, Brockmoller J, Bauer S, Roots I | Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences. AMERICAN JOURNAL OF HUMAN GENETICS 60: (2) 284-295 FEB 1997 | 112 |
| 5. | Noe B, Hagenbuch B, Stieger B, Meier PJ | Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. PROC NAT ACAD SCI USA 94: (19) 10346-10350 SEP 16 1997 | 109 |
| 6. | Ludwig A, Zong XG, Jeglitsch M, Hofmann F, Biel M | A family of hyperpolarization-activated mammalian cation channels. NATURE 393: (6685) 587-591 JUN 11 1998 | 98 |
| 7. | Albuquerque EX, Alkondon M, Pereira EFR, Castro NG, Schrattenholz A, Barbosa CTF, BonfanteCabarcas R, Aracava Y, Eisenberg HM, Maelicke A | Properties of neuronal nicotinic acetylcholine receptors: Pharmacological characterization and modulation of synaptic function. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 280: (3) 1117-1136 MAR 1997 | 94 |
| 8. | Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU | The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. OF BIOL. CHEMISTRY 272: (12) 7727-7731 MAR 21 1997 | 89 |
| 9. | Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, Aktories K | Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. NATURE 387: (6634) 725-729 JUN 12 1997 | 86 |
| 10. | Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G | Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. NATURE 397: (6716) 259-263 JAN 21 1999 | 84 |
Die meistzitierten Reviews |
|||
| Rang | Autoren | Paper | Zitierungen |
| 1. | Wehling M | Specific, nongenomic actions of steroid hormones. ANNUAL REVIEW OF PHYSIOLOGY 59: 365-393 1997 | 176 |
| 2. | Herdegen T, Skene P, Bahr M | The c-Jun transcription factor - Bipotential mediator of neuronal death, survival and regeneration. TRENDS IN NEUROSCIENCES 20: (5) 227-231 MAY 1997 | 156 |
| 3. | Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T | XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. PHARMACOLOGICAL REVIEWS 50: (1) 143-150 MAR 1998 | 119 |
| 4. | Meyer UA, Zanger UM | Molecular mechanisms of genetic polymorphisms of drug metabolism. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 37: 269-296 1997 | 120 |
Die meistzitierten Köpfe |
||||
| Rang | Name | Ort | Zitierungen | Artikel |
| 1. | Günter Schultz | Pharmakol. FU Berlin | 663 | 29 |
| 2. | Jean-Marc Fritschy | Pharmakol. Uni Zürich | 655 | 35 |
| 3. | Peter Meier-Abt | Klin. Phamakol. & Toxikol. Uni Zürich | 600 | 33 |
| 4. | Franz Hofmann | Pharmakol. & Toxikol. TU München | 592 | 33 |
| 5. | Josef Pfeilschifter | Zentrum Pharmakol. Uni Frankfurt / Basel | 504 | 41 |
| 6. | Klaus Aktories | Pharmakol. & Toxikol. Uni Freiburg | 473 | 35 |
| 7. | Bruno Stieger | Klin. Pharmakol. & Toxikol. Unispital Zürich | 451 | 25 |
| 8. | Stefan Offermanns | Pharmakol. Heidelberg / FU Berlin | 417 | 12 |
| 9. | Hans-Uwe Simon | Pharmakol. Uni Bern / SIAF Zürich | 412 | 18 |
| 10. | Ivar Roots | Klin. Pharmakol. Charité HU Berlin | 411 | 39 |
| 11. | Jürgen C. Frölich | Klin. Pharmakol. MH Hannover | 411 | 33 |
| 12. | Martin C. Michel | Klin. Pharmakol. Uni Essen | 407 | 49 |
| 13. | Dietmar Benke | Pharmakol. ETH & Uni Zürich | 397 | 16 |
| 14. | Detlev Ganten | Klin. Pharmakol. FU Berlin / MDC Berlin | 383 | 54 |
| 15. | Karl H. Jakobs | Pharmakol. Uni Essen | 381 | 22 |
| 16. | Bruno Hagenbuch | Klin. Pharmakol. Uni Zürich | 371 | 16 |
| 17. | Hans Peter Hauri | Pharmakol. Biozentrum Uni Basel | 344 | 13 |
| 18. | Michael Beyermann | Forschungsinst. f. Mol. Pharmakol. Berlin | 339 | 27 |
| 19. | Albrecht Wendel | Biochemie & Pharmakol. Uni Konstanz | 332 | 28 |
| 20. | Jürgen Brockmöller | Klin. Pharmakol. Uni Göttingen / HU Berlin | 331 | 23 |
| 21. | Martin J. Lohse | Pharmkol & Toxikol. Uni Würzburg | 327 | 22 |
| 22. | Thomas Gudermann | Pharmakol. Uni Marburg / FU Berlin | 327 | 18 |
| 23. | Volker Höllt | Pharmakol. & Toxikol. Uni Magdeburg | 324 | 32 |
| 24. | Stefanie Bode-Böger | Klin. Pharmakol. MH Hannover | 324 | 17 |
| 25. | Hanns Möhler | Pharmakol. ETH & Uni Zürich | 321 | 17 |
| 26. | Rainer H. Böger | Klin. Pharmakol. MH Hannover | 319 | 18 |
| 27. | Thomas Unger | Pharmakol. & Toxikol. Uni Kiel | 312 | 35 |
| 28. | Radek C. Skoda | DKFZ Heidelberg / Pharmakol. Uni Basel | 303 | 8 |
| 29. | Thomas Herdegen | Pharmakol. Uni Kiel | 294 | 24 |
| 30. | Hartmut Oschkinat | Forsch.-Inst. f. Mol. Pharmakol. Berlin | 293 | 22 |
| 31. | Ulrich Förstermann | Pharmakol. Uni Mainz | 290 | 23 |
| 32. | Helmut Holtmann | Pharmakol. MH Hannover | 276 | 7 |
| 33. | Doris Koesling | Pharmakol. Uni Bochum / FU Berlin | 275 | 18 |
| 34. | Niko Ghilardi | Pharmakol. Biozentrum Uni Basel | 264 | 6 |
| 35. | Winfried Siffert | Pharmakol. Uni Essen | 263 | 15 |
| 36. | Andreas Ludwig | Pharmakol. & Toxikol. TU München | 251 | 9 |
| 37. | Michael Bienert | Forsch.-Inst. Mol. Pharmakol. Berlin | 248 | 23 |
| 38. | Veit Flockerzi | Pharmakol. Uni Homburg | 245 | 13 |
| 39. | Klaus Resch | Mol. Pharmakol. MH Hannover | 243 | 16 |
| 40. | Wojciech Danysz | Abt. Pharmakol. Merz & Co. Frankfurt | 241 | 27 |
| 41. | Walter E. Müller | Pharmakol. Uni Frankfurt | 240 | 29 |
| 42. | Steffen Bauer | Klin. Pharmakol. Charité HU Berlin | 240 | 16 |
| 43. | Josef Krieglstein | Pharm. & Toxikol. Uni Marburg | 239 | 27 |
| 44. | Klaus Starke | Pharmakol. & Toxikol. Uni Freiburg | 238 | 23 |
| 45. | Karsten Schrör | Pharmakol. & Klin. Pharmakol. Uni Düsseldorf | 236 | 30 |
| 46. | Wolfgang Löscher | Pharmakol. | 236 | 61 |
| 47. | Thomas Eschenhagen | Pharmakol. Uni Erlangen / Uni Hamburg | 234 | 19 |
| 48. | Vincent Mutel | Div. Pharma Hoffman La Roche Basel | 232 | 20 |
| 49. | Fred Hofmann | Pharmakol. & Toxikol. Uni Freiburg | 232 | 15 |
| 50. | Lutz Hein | Pharmkol. & Toxikol. Uni Würzburg | 231 | 9 |
